NCT00401362View on ClinicalTrials.gov

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Advanced Illness Patients With Opioid Induced Constipation

Interventions

DRUG

SC Methylnaltrexone

Dose 1

DRUG

SC Placebo

DRUG

SC Methylnaltrexone

Dose 2

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Bausch Health Americas, Inc.

INDUSTRY